Munich Re has announced that it will terminate new investments from Munich Re Ventures (MRV), its venture unit created ten years ago to accelerate innovation in insurance and risk management. With $1.2 billion and a portfolio of around 100 startups, including Hippo, Augury and Next Insurance, MRV had become one of the most structured and influential corporate VCs in the sector. The reinsurer’s decision marks a strategic shift at a time when climate, technological and cyber risks are increasing.
Ten years of structured innovation in a traditional group
Founded and led by Jacqueline LeSageMRV’s mission was to identify emerging technologies and models capable of transforming the underwriting, machine diagnostics or insurance of digital assets. The fund combined rare financial capacity and direct proximity to the risk professions, allowing startups to access data, internal expertise and operational contracts.
In ten years, MRV has generated both significant financial returns And a strong strategic value. The most emblematic example remains Next Insurancesupported from its beginnings then acquired for 2.6 billion dollars. Another illustration of the fund’s journey: the HSB partnership with At-Bay, which has become a benchmark in cyber insurance.
Why Munich Re is changing its model
Munich Re believes that its business lines, from reinsurance to cyber to industrial services, now have mature capabilities to source and manage their collaborations with startups themselves. Innovation must be internalized “close to the ground”, rather than managed by a separate venture structure.
The group also explains that it wants to consolidate all VC activities under MEAG, its asset management arm, in order to unify processes and improve operational efficiency. MEAG will take charge of the remaining venture investments, as well as future co-investment opportunities, but with a purely financial logic.
A repositioning, not an exit from venture capital
Munich Re will continue to invest in the asset class through external funds and co-investments made by MEAG. A dedicated transition team will support the changeover period in order to guarantee the continuity of monitoring of investments and the preservation of the value of the portfolio.
A female executive at the head of a major European CVC
Directed since its creation by Jacqueline LeSageMRV constituted a rare example of a large-scale corporate venture led by a woman in a historically male sector. Its trajectory and the role played in the structuring of an international insurtech ecosystem give this closure an additional managerial and cultural dimension.
What this says about the European market
Munich Re’s decision highlights three fundamental developments in European insurtech:
- A refocusing of corporate VC. Dedicated funds give way to systems integrated into the professions.
- Increased market maturity. Cycles of insurtech disruption have slowed down, in favor of more capital-intensive models closer to operational needs.
- New internal arbitrations. The groups favor pragmatic approaches, oriented to immediate ROI, rather than broad-spectrum exploration programs.
